These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27999208)

  • 1. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.
    Zurita M; Lara PC; del Moral R; Torres B; Linares-Fernández JL; Arrabal SR; Martínez-Galán J; Oliver FJ; Ruiz de Almodóvar JM
    BMC Cancer; 2010 May; 10():217. PubMed ID: 20487521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.
    Martínez-Galán J; Torres B; Del Moral R; Muñoz-Gámez JA; Martín-Oliva D; Villalobos M; Núñez MI; Luna Jde D; Oliver FJ; Ruiz de Almodóvar JM
    Cancer Biol Ther; 2008 Jun; 7(6):958-65. PubMed ID: 18379196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the association between APC promoter methylation and breast cancer.
    He K; Zhang L; Long X
    Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
    Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W
    Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
    Ye M; Huang T; Ni C; Yang P; Chen S
    EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.
    Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL
    Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation and breast cancer: A way forward (Review).
    Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
    Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
    Akahira J; Sugihashi Y; Suzuki T; Ito K; Niikura H; Moriya T; Nitta M; Okamura H; Inoue S; Sasano H; Okamura K; Yaegashi N
    Clin Cancer Res; 2004 Apr; 10(8):2687-93. PubMed ID: 15102672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer.
    Wang YJ; He L; Yuan M; Tsang WW; Hao L; Wang M; Chow LW; Cheung MN; Liu Q; Ng EL; Loo WT; Chow CY; Bai LJ; Yang Z
    Int J Biol Markers; 2014 Sep; 29(3):e208-14. PubMed ID: 25041782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
    Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
    Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients.
    Rokni P; Shariatpanahi AM; Sakhinia E; Kerachian MA
    Genes Genomics; 2018 Apr; 40(4):423-428. PubMed ID: 29892846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DFNA5 promoter methylation a marker for breast tumorigenesis.
    Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G
    Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.